The cr papers and the recent commentary in the webinar show a renaissance for ALT. It has recognised it is an R & D company and will do a licence deal with an mjor to market both The PeriCoach and the Burette. The share issues to Dr Mansour and others are not only capital raising but to takeover protect the company from low ball offers.
